Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

In patients with t(8;21) acute myeloid leukemia (AML), recurrent minimal residual disease (MRD) measured by RUNX1-RUNX1T1 transcript levels can predict relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT). This study aimed to compare the efficacy of preemptive interferon (IFN...

Full description

Bibliographic Details
Main Authors:	Shuang Fan, Meng-Zhu Shen, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Xiao-Su Zhao, Ya-Zhen Qin, Ying-Jun Chang, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Dong Mo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Oncology
Subjects:	RUNX1-RUNX1T1 allogeneic hematopoietic stem cell transplantation preemptive interferon donor lymphocyte infusion
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.773394/full

Similar Items

The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia
by: Ya-Zhen Qin, et al.
Published: (2017-02-01)

Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation
by: Ya-Zhen Qin, et al.
Published: (2016-05-01)

Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation
by: Yutong Tang, et al.
Published: (2022-02-01)

Risk factors for post-transplant relapse and survival in younger adult patients with t(8;21)(q22;q22) acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: A multicenter retrospective study
by: Wei Zhou, et al.
Published: (2023-02-01)

Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis
by: Shuang Fan, et al.
Published: (2023-02-01)

Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies
by: Meng-Zhu Shen, et al.
Published: (2022-01-01)

Application of prophylactic or pre-emptive therapy after allogeneic transplantation for high-risk patients with t(8;21) acute myeloid leukemia
by: Wenwen Guo, et al.
Published: (2023-12-01)

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01)

RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
by: Justin Loke, et al.
Published: (2017-05-01)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
by: Linda Shyue Huey Chuang, et al.
Published: (2021-10-01)

Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Giorgia Battipaglia, et al.
Published: (2022-03-01)

Myeloid/Lymphoid Neoplasm With FGFR1 Rearrangement Accompanying RUNX1 and NOTCH1 Gene Mutations
by: Xiaoxue Wang, et al.
Published: (2019-11-01)

Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients
by: Peggy Kanellou, et al.
Published: (2023-03-01)

RUNX Family in Hypoxic Microenvironment and Angiogenesis in Cancers
by: You Mie Lee
Published: (2022-10-01)

Different Requirements of CBFB and RUNX2 in Skeletal Development among Calvaria, Limbs, Vertebrae and Ribs
by: Qing Jiang, et al.
Published: (2022-10-01)

Wilms’ tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Dao-Xing Deng, et al.
Published: (2021-03-01)

The RUNX Family of Proteins, DNA Repair, and Cancer
by: Vaidehi Krishnan
Published: (2023-04-01)

A transcriptional landscape of 28 porcine tissues obtained by super deepSAGE sequencing
by: Tinghua Huang, et al.
Published: (2020-03-01)

Anti-inflammatory and anti-osteoarthritis effects of tectorigenin
by: Cheng-Long Wang, et al.
Published: (2017-08-01)

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
by: Xiao-hui Zhang, et al.
Published: (2021-09-01)

Efficacy of donor lymphocyte infusion in patients after different types of allogeneic hematopoietic stem cell transplantation
by: O A Slesarchuk, et al.
Published: (2013-07-01)

The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
by: Adiba S. Khan, et al.
Published: (2023-02-01)

Runx Transcription Factors in T Cells—What Is Beyond Thymic Development?
by: Svetlana Korinfskaya, et al.
Published: (2021-08-01)

Hemophagocytic Lymphohistiocytosis in RUNX1: : RUNX1T1 Positive AML with Blast Count Below 20%
by: Xingqin Huang, et al.
Published: (2023-08-01)

<i>AML1-ETO</i>-Related Fusion Circular RNAs Contribute to the Proliferation of Leukemia Cells
by: Ying Wang, et al.
Published: (2022-12-01)

RAG1 co‐expression signature identifies ETV6‐RUNX1‐like B‐cell precursor acute lymphoblastic leukemia in children
by: Dongfeng Chen, et al.
Published: (2021-06-01)

Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma
by: Rong Deng, et al.
Published: (2020-08-01)

Loss of runx1 function results in B cell immunodeficiency but not T cell in adult zebrafish
by: Yali Chi, et al.
Published: (2018-07-01)

2,3,5,4′-Tetrahydroxy-stilbene-2-O-beta-d-glucoside induces autophagy-mediated apoptosis in hepatocytes by upregulating miR-122 and inhibiting the PI3K/Akt/mTOR pathway: implications for its hepatotoxicity
by: Lei Yang, et al.
Published: (2020-01-01)

A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-03-01)

Runx1t1 promotes the neuronal differentiation in rat hippocampus
by: Linqing Zou, et al.
Published: (2020-04-01)

Prognostic Impacts of D816V <i>KIT</i> Mutation and Peri-Transplant <i>RUNX1–RUNX1T1</i> MRD Monitoring on Acute Myeloid Leukemia with <i>RUNX1–RUNX1T1</i>
by: Byung-Sik Cho, et al.
Published: (2021-01-01)

t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming
by: Sophie Kellaway, et al.
Published: (2020-12-01)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
by: Enrico Maffini, et al.
Published: (2022-11-01)

Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
by: Chao Yangfa, et al.
Published: (2023-08-01)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
by: Natalia B. Fernández, et al.
Published: (2023-01-01)

Beyond Pathogenic <i>RUNX1</i> Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies
by: Alisa Förster, et al.
Published: (2022-07-01)

Genomic-wide transcriptional profiling in primary myoblasts reveals Runx1-regulated genes in muscle regeneration
by: Kfir Baruch Umansky, et al.
Published: (2015-12-01)

Aurora kinase-induced phosphorylation excludes transcription factor RUNX from the chromatin to facilitate proper mitotic progression
by: Chuang, Linda Shyue Huey, et al.
Published: (2017)

Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
by: Jing Liu, et al.
Published: (2018-01-01)